Biopartitioning micellar chromatography to predict mutagenicity of aromatic amines

European Journal of Medicinal Chemistry
2007.0

Abstract

Mutagenicity is a toxicity endpoint associated with the chronic exposure to chemicals. Aromatic amines have considerable industrial and environmental importance due to their widespread use in industry and their mutagenic capacity. Biopartitioning micellar chromatography (BMC), a mode of micellar liquid chromatography that uses micellar mobile phases of Brij35 in adequate experimental conditions, has demonstrated to be useful in mimicking the drug partitioning process into biological systems. In this paper, the usefulness of BMC for predicting mutagenicity of aromatic amines is demonstrated. A multiple linear regression (MLR) model based on BMC retention data is proposed and compared with other ones reported in bibliography. The proposed model present better or similar descriptive and predictive capability.

Knowledge Graph

Similar Paper

Biopartitioning micellar chromatography to predict mutagenicity of aromatic amines
European Journal of Medicinal Chemistry 2007.0
Development of Predictive Retention−Activity Relationship Models of Tricyclic Antidepressants by Micellar Liquid Chromatography
Journal of Medicinal Chemistry 1999.0
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity
Journal of Medicinal Chemistry 1991.0
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines
Journal of Medicinal Chemistry 1981.0
7-Azabicyclo[2.2.1]heptane as a structural motif to block mutagenicity of nitrosamines
Bioorganic & Medicinal Chemistry 2011.0
Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2002.0
Potential antitumor agents. 30. Mutagenic activity of some 9-anilinoacridines: relationships between structure, mutagenic potential, and antileukemic activity
Journal of Medicinal Chemistry 1979.0
Potential antitumor agents. 33. Quantitative structure-activity relationships for mutagenic activity and antitumor activity of substituted 4'-(9-acridinylamino)methanesulfonanilide derivatives
Journal of Medicinal Chemistry 1980.0
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogs
Journal of Medicinal Chemistry 1979.0
Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2020.0